COVID-19 Vaccine Associated Anaphylaxis
Peer-Reviewed Scientific papers regarding COVID-19 Vaccine Associated Anaphylaxis
COVID-19 vaccine-associated anaphylaxis: a statement from the Anaphylaxis Committee of the World Allergy Organization
Allergic reactions, including anaphylaxis, after receiving the first dose of the Pfizer-BioNTech COVID-19 vaccine
Allergic reactions, including anaphylaxis, after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine – United States, December 14-23, 2020
Allergic reactions, including anaphylaxis, after receiving first dose of Modern COVID-19 vaccine – United States, December 21, 2020-January 10, 2021
Reports of anaphylaxis after coronavirus disease vaccination 2019, South Korea, February 26-April 30, 2021
Reports of anaphylaxis after receiving COVID-19 mRNA vaccines in the U.S.-Dec 14, 2020-Jan 18, 2021
Immunization practices and risk of anaphylaxis: a current, comprehensive update of COVID-19 vaccination data
Relationship between pre-existing allergies and anaphylactic reactions following administration of COVID-19 mRNA vaccine
Anaphylaxis Associated with COVID-19 mRNA Vaccines: Approach to Allergy Research
Allergic reactions and anaphylaxis to LNP-based COVID-19 vaccines
Cumulative adverse event report of anaphylaxis following injections of COVID-19 mRNA vaccine (Pfizer-BioNTech) in Japan: the first month report
COVID-19 vaccines increase the risk of anaphylaxis
Biphasic anaphylaxis after exposure to the first dose of the Pfizer-BioNTech COVID-19 mRNA vaccine COVID-19
Polyethylene glycol (PEG) is a cause of anaphylaxis to Pfizer / BioNTech mRNA COVID-19 vaccine
Elevated rates of anaphylaxis after vaccination with Pfizer BNT162b2 mRNA vaccine against COVID-19 in Japanese healthcare workers; a secondary analysis of initial post-approval safety data
IgE-mediated allergy to polyethylene glycol (PEG) as a cause of anaphylaxis to COVID-19 mRNA vaccines
Anaphylactic reactions to COVID-19 mRNA vaccines: a call for further study
Anaphylaxis following Covid-19 vaccine in a patient with cholinergic urticaria
Anaphylaxis induced by CoronaVac COVID-19 vaccine: clinical features and results of revaccination.
Anaphylaxis after Modern COVID-19 vaccine
Sex differences in the incidence of anaphylaxis to LNP-mRNA vaccines COVID-19
Allergic reactions, including anaphylaxis, after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine – United States, December 14 to 23, 2020
Allergic reactions, including anaphylaxis, after receiving the first dose of Modern COVID-19 vaccine – United States, December 21, 2020 to January 10, 2021
Prolonged anaphylaxis to Pfizer 2019 coronavirus disease vaccine: a case report and mechanism of action
Anaphylaxis reactions to Pfizer BNT162b2 vaccine: report of 3 cases of anaphylaxis following vaccination with Pfizer BNT162b2
Biphasic anaphylaxis after first dose of 2019 messenger RNA coronavirus disease vaccine with positive polysorbate 80 skin test result
Biphasic anaphylaxis after exposure to the first dose of Pfizer-BioNTech COVID-19 mRNA vaccine COVID-19
Biphasic anaphylaxis after exposure to the first dose of Pfizer-BioNTech COVID-19 mRNA vaccine COVID-19
Cumulative Adverse Event Reporting of Anaphylaxis After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japan
Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine – United States